Medmix

Medmix, headquartered in Switzerland, operates in the "Other business services" industry. In 2024, the company reported total Scope 1, 2, and 3 emissions of approximately 73.586 million kg CO2e. This included 4.351 million kg CO2e from Scope 1, 5.88 million kg CO2e from Scope 2, and 63.355 million kg CO2e from Scope 3.

Looking back, Medmix's emissions were approximately 65.659 million kg CO2e in 2023, with Scope 1 at 4.381 million kg CO2e, Scope 2 at 1.214 million kg CO2e, and Scope 3 at 60.044 million kg CO2e. In 2022, emissions totalled approximately 74.756 million kg CO2e, comprising 5.408 million kg CO2e for Scope 1, 1.545 million kg CO2e for Scope 2, and 67.803 million kg CO2e for Scope 3. For 2025, Medmix has only reported Scope 1 emissions, which are approximately 4.127 million kg CO2e.

Medmix has established ambitious climate commitments, with Science Based Targets initiative (SBTi) validated targets. The company commits to reaching net-zero greenhouse gas emissions across its value chain by 2050. Near-term targets include an 80% absolute reduction in Scope 1 and 2 GHG emissions by 2029, compared to a 2019 base year. Additionally, Medmix aims to reduce absolute Scope 3 GHG emissions from specific categories (purchased goods and services, capital goods, fuel- and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, and employee commuting) by 42% within the same timeframe. Long-term targets include a 90% absolute reduction in Scope 1, 2, and 3 GHG emissions by 2050 from a 2019 base year. These targets are consistent with reductions required to keep global warming to 1.5°C. Medmix has also set a direct document reduction target of a 50% reduction in CO2 carbon footprint absolute emissions by 2030, compared to 2019. All emissions data and climate commitments are directly from Medmix AG.